*Contraindications weight loss injections include a personal or family history of medullary thyroid cancer, allergy to GLP-1 and weight loss injections, Type 1 Diabetes or history of Diabetic Ketoacidosis, personal or family history of Multiple Endocrine Neoplasia, personal history of Pancreatitis, renal impairment or kidney disease, gallbladder disease, or concurrent use of anti-diabetic medications or insulin
CYP2B6 and perhaps CYP2C9: Inhibitors may increase propofol levels
Efficacy of ipamorelin, a ghrelin mimetic, on gastric dysmotility in a rodent model of postoperative ileus
This results in reduced ion conductance and a fade pattern similar to nondepolarizing blockade
2.3 Statistical methods The study compared whether there were significant differences in proportion of gender, age, and weight across AEs between the serious and non-serious outcomes among the different medications (including albiglutide, exenatide, dulaglutide, liraglutide, semaglutide, and tirzepatide)